NCT01941082View on ClinicalTrials.gov

A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Macular Degeneration
Interventions
DRUG

RO6867461

Single or multiple ascending dose by intravitreal injection

Trial Locations (8)

21287

Baltimore

22908

Charlottesville

75231

Dallas

77030

Houston

80909

Colorado Springs

BT12 6BA

Belfast

BS1 2LX

Bristol

EC1V 2PD

London

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01941082 - A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter